Your company account is blocked and you cannot place orders. If you have questions, please contact your company administrator.

(S)-3-{2-[(S)-2-((S)-2-{(S)-2-[(S)-2-Acetylamino-3-(4-phosphonooxy-phenyl)-propionylamino]-3-methyl-butyrylamino}-4-methyl-pentanoylamino)-4-carbamoyl-butyrylamino]-acetylamino}-succinamic acid

ID: ALA156448

PubChem CID: 24768169

Max Phase: Preclinical

Molecular Formula: C33H51N8O14P

Molecular Weight: 814.79

Molecule Type: Protein

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(N)=O)C(C)C

Standard InChI:  InChI=1S/C33H51N8O14P/c1-16(2)12-23(31(49)39-21(10-11-25(34)43)30(48)36-15-26(44)38-22(29(35)47)14-27(45)46)40-33(51)28(17(3)4)41-32(50)24(37-18(5)42)13-19-6-8-20(9-7-19)55-56(52,53)54/h6-9,16-17,21-24,28H,10-15H2,1-5H3,(H2,34,43)(H2,35,47)(H,36,48)(H,37,42)(H,38,44)(H,39,49)(H,40,51)(H,41,50)(H,45,46)(H2,52,53,54)/t21-,22-,23-,24-,28-/m0/s1

Standard InChI Key:  WBCJXAXDKSPVKS-OPHJYBJGSA-N

Molfile:  

     RDKit          2D

 56 56  0  0  1  0  0  0  0  0999 V2000
    4.0875   -2.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3583    0.0833    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    2.6542   -2.8125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9375   -3.2250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2292   -3.2250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8042   -3.2250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3667   -3.2250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9542   -2.8125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9667   -4.0542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9667   -3.2250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5167   -2.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3792   -2.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2167   -2.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6792   -2.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2500   -2.8125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5042   -3.2250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6792   -4.4667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6667   -3.2250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5292   -3.2250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1000   -3.2250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5042   -4.0500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6458   -0.3292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.3792   -5.2917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9458    0.8000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0875   -1.9875    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9375   -4.0542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2292   -4.0542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2167   -1.9875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3792   -1.9875    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.3917   -3.2250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5167   -1.9875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6792   -5.2917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.5292   -4.0542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2167   -4.4625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.1000   -5.7042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6667   -4.0542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0750    0.4958    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7750   -0.6292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8167   -2.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6792   -1.9875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3667   -4.0542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3792   -4.4667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9250   -0.7417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6667   -5.7042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5042   -1.5750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3917   -4.0542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5042   -0.7417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2125   -1.9875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2125   -0.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9250   -1.5750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2292   -1.5750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2083   -4.4625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6542   -4.4667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0875   -4.4667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9542   -1.9875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2292   -0.7417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2 22  1  0
  3  7  1  0
  4  3  1  0
  5 11  1  0
  6  1  1  0
  7  1  1  0
  8  5  1  0
 10  9  1  6
 10 15  1  0
 11  6  1  0
 12 18  1  0
 13  4  1  0
 14 10  1  0
 15 19  1  0
 16 13  1  0
 17  9  1  0
 18  8  1  0
 19 39  1  0
 20 12  1  0
 21 16  1  0
 22 43  1  0
 23 42  1  0
 24  2  2  0
 25  1  2  0
 26  4  2  0
 27  5  2  0
 13 28  1  1
 29 12  2  0
 30 14  2  0
 11 31  1  1
 32 17  2  0
 33 19  2  0
 34 21  2  0
 35 23  2  0
 18 36  1  6
 37  2  1  0
 38  2  1  0
 39 20  1  0
 40 14  1  0
  7 41  1  6
 42 36  1  0
 43 50  1  0
 44 23  1  0
 45 28  1  0
 46 17  1  0
 47 45  2  0
 48 45  1  0
 49 47  1  0
 50 48  2  0
 51 31  1  0
 52 21  1  0
 53 41  1  0
 54 41  1  0
 55 51  1  0
 56 51  1  0
 49 43  2  0
M  END

Alternative Forms

  1. Parent:

    ALA156448

    Y(p)VLQGD

Associated Targets(Human)

STAT3 Tchem Signal transducer and activator of transcription 3 (3313 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Calculated Properties

Molecular Weight: 814.79Molecular Weight (Monoisotopic): 814.3262AlogP: -2.81#Rotatable Bonds: 24
Polar Surface Area: 364.84Molecular Species: ACIDHBA: 11HBD: 11
#RO5 Violations: 3HBA (Lipinski): 22HBD (Lipinski): 13#RO5 Violations (Lipinski): 3
CX Acidic pKa: 1.78CX Basic pKa: CX LogP: -3.78CX LogD: -10.13
Aromatic Rings: 1Heavy Atoms: 56QED Weighted: 0.05Np Likeness Score: 0.08

References

1. Ren Z, Cabell LA, Schaefer TS, McMurray JS..  (2003)  Identification of a high-affinity phosphopeptide inhibitor of Stat3.,  13  (4): [PMID:12639546] [10.1016/s0960-894x(02)01050-8]
2. Mandal, Pijus K PK and 9 more authors.  2009-04-23  Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modeling.  [PMID:19334714]
3. Mandal, Pijus K; Ren, Zhiyong; Chen, Xiaomin; Xiong, Chiyi and McMurray, John S.  2009-10-08  Structure-affinity relationships of glutamine mimics incorporated into phosphopeptides targeted to the SH2 domain of signal transducer and activator of transcription 3.  [PMID:19728728]
4. Ioannidis, Stephanos S and 20 more authors.  2011-01-13  Discovery of 5-chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a novel inhibitor of the Jak/Stat pathway.  [PMID:21138246]
5. Mandal, Pijus K and 10 more authors.  2011-05-26  Potent and selective phosphopeptide mimetic prodrugs targeted to the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3.  [PMID:21486047]
6. Ren, Xiaomei X and 8 more authors.  2010-12-09  Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway.  [PMID:24900231]
7. Haftchenary, Sina S and 15 more authors.  2013-11-14  Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma.  [PMID:24900612]
8. LaPorte, Matthew G and 11 more authors.  2014-11-01  2-Guanidinoquinazolines as new inhibitors of the STAT3 pathway.  [PMID:25288188]
9. Miklossy, Gabriella G and 15 more authors.  2015-10-08  Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin α-2 Expression, and Induce Antitumor Effects against Human Glioma.  [PMID:26331426]
10. Löcken, Hauke H, Clamor, Cinzia C and Müller, Klaus K.  2018-07-27  Napabucasin and Related Heterocycle-Fused Naphthoquinones as STAT3 Inhibitors with Antiproliferative Activity against Cancer Cells.  [PMID:30003778]
11. Huang, Wei W and 8 more authors.  2018-09-05  Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis.  [PMID:30145375]
12. Chen, Shao-Ru SR and 7 more authors.  2018-10-01  Andrographolide derivative as STAT3 inhibitor that protects acute liver damage in mice.  [PMID:30228000]
13. Li, Chungen C and 8 more authors.  2019-01-15  A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3 (STAT3).  [PMID:30472602]
14. Zhou, Haibin and 18 more authors.  2019-12-26  Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein.  [PMID:31747516]
15. Kaoud, Tamer S and 7 more authors.  2020-01-15  NO-releasing STAT3 inhibitors suppress BRAF-mutant melanoma growth.  [PMID:31784187]
16. Cerulli, Robert A and 6 more authors.  2020-06-15  Cytosolic delivery of peptidic STAT3 SH2 domain inhibitors.  [PMID:32503696]
17. Brotherton-Pleiss, Christine and 13 more authors.  2021-01-14  Discovery of Novel Azetidine Amides as Potent Small-Molecule STAT3 Inhibitors.  [PMID:33352047]

Source